New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Updates on Imaging-Based Pancreatic Cancer Surveillance for Individuals With Increased Genetic and Familial Risk

Updates on Imaging-Based Pancreatic Cancer Surveillance for Individuals With Increased Genetic and Familial Risk

August 15, 2023Matthew B. Yurgelun, MDRecent years have brought tremendous progress in demonstrating that there is hope for improving mortality from pancreatic ductal adenocarcinoma through early dete
World medicine November 25,2023
Updates on Imaging-Based Pancreatic Cancer Surveillance for Individuals With Increased Genetic and Familial Risk

Updates on Imaging-Based Pancreatic Cancer Surveillance for Individuals With Increased Genetic and Familial Risk

August 15, 2023Matthew B. Yurgelun, MDRecent years have brought tremendous progress in demonstrating that there is hope for improving mortality from pancreatic ductal adenocarcinoma through early dete
World medicine November 25,2023
Advances in Early-Stage Breast Cancer Pull Biology and Biomarkers Into Focus

Advances in Early-Stage Breast Cancer Pull Biology and Biomarkers Into Focus

July 25, 2023OncLive StaffAs new data emerge in breast cancer, stepping back from the updates and shedding light on the standard practices as they exist in the clinic are crucial approaches to managem
World medicine November 25,2023
Advances in Early-Stage Breast Cancer Pull Biology and Biomarkers Into Focus

Advances in Early-Stage Breast Cancer Pull Biology and Biomarkers Into Focus

July 25, 2023OncLive StaffAs new data emerge in breast cancer, stepping back from the updates and shedding light on the standard practices as they exist in the clinic are crucial approaches to managem
World medicine November 25,2023
First-Line Rivoceranib Plus Camrelizumab Improves Survival in Unresectable HCC

First-Line Rivoceranib Plus Camrelizumab Improves Survival in Unresectable HCC

July 25, 2023Chris RyanTreatment with the combination of rivoceranib and camrelizumab led to a statistically significant and clinically meaningful benefit in progression-free survival and overall surv
World medicine November 25,2023
First-Line Rivoceranib Plus Camrelizumab Improves Survival in Unresectable HCC

First-Line Rivoceranib Plus Camrelizumab Improves Survival in Unresectable HCC

July 25, 2023Chris RyanTreatment with the combination of rivoceranib and camrelizumab led to a statistically significant and clinically meaningful benefit in progression-free survival and overall surv
World medicine November 25,2023
Novel Agents Highlight Changes in Myeloma Field

Novel Agents Highlight Changes in Myeloma Field

July 11, 2023Kyle DohertyLeading investigators in the multiple myeloma field discuss the latest clinical trial findings, many of which were presented during the 2023 ASCO Annual Meeting.Elizabeth “Bet
World medicine November 25,2023
Novel Agents Highlight Changes in Myeloma Field

Novel Agents Highlight Changes in Myeloma Field

July 11, 2023Kyle DohertyLeading investigators in the multiple myeloma field discuss the latest clinical trial findings, many of which were presented during the 2023 ASCO Annual Meeting.Elizabeth “Bet
World medicine November 25,2023
Frontline Lenvatinib Plus Pembrolizumab Produces Superior Responses Vs Sunitinib in Advanced RCC

Frontline Lenvatinib Plus Pembrolizumab Produces Superior Responses Vs Sunitinib in Advanced RCC

July 14, 2023Russ ConroyLenvatinib plus pembrolizumab demonstrated improved overall response rates compared with sunitinib monotherapy in treatment-naïve patients with advanced renal cell carcinoma re
World medicine November 25,2023
Frontline Lenvatinib Plus Pembrolizumab Produces Superior Responses Vs Sunitinib in Advanced RCC

Frontline Lenvatinib Plus Pembrolizumab Produces Superior Responses Vs Sunitinib in Advanced RCC

July 14, 2023Russ ConroyLenvatinib plus pembrolizumab demonstrated improved overall response rates compared with sunitinib monotherapy in treatment-naïve patients with advanced renal cell carcinoma re
World medicine November 25,2023
Researchers announce a new genetic classification system for gastric cancer

Researchers announce a new genetic classification system for gastric cancer

Reviewed byMegan Craig, M.Sc.Nov 6 2023Professor Sang Cheul Oh of the Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Professor Sang‑Hee K
World medicine November 25,2023
Researchers announce a new genetic classification system for gastric cancer

Researchers announce a new genetic classification system for gastric cancer

Reviewed byMegan Craig, M.Sc.Nov 6 2023Professor Sang Cheul Oh of the Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Professor Sang‑Hee K
World medicine November 25,2023
Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

ByDr. Sushama R. Chaphalkar, PhD.Nov 8 2023Reviewed byLily Ramsey, LLMIn a recent study published in theJournal of American Medical Association (JAMA) Oncology, researchers from Cali
World medicine November 25,2023
Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

Can adding RNA sequencing to germline genetic testing improve accuracy and clinical sensitivity over time compared to DNA sequencing alone?

ByDr. Sushama R. Chaphalkar, PhD.Nov 8 2023Reviewed byLily Ramsey, LLMIn a recent study published in theJournal of American Medical Association (JAMA) Oncology, researchers from Cali
World medicine November 25,2023
Virtual brain bank creates a powerful resource for research on epilepsy, brain tumors

Virtual brain bank creates a powerful resource for research on epilepsy, brain tumors

Reviewed byLily Ramsey, LLMNov 6 2023A new virtual brain bank spanning five Chicago academic medical centers and led by University of Illinois Chicago will create a powerful new resource for cli
World medicine November 25,2023
Virtual brain bank creates a powerful resource for research on epilepsy, brain tumors

Virtual brain bank creates a powerful resource for research on epilepsy, brain tumors

Reviewed byLily Ramsey, LLMNov 6 2023A new virtual brain bank spanning five Chicago academic medical centers and led by University of Illinois Chicago will create a powerful new resource for cli
World medicine November 25,2023
AI could revolutionize sudden cardiac death prediction and prevention

AI could revolutionize sudden cardiac death prediction and prevention

Reviewed byMegan Craig, M.Sc.Nov 6 2023Predicting sudden cardiac death, and perhaps even addressing a person's risk to prevent future death, may be possible through artificial intelligence (
World medicine November 25,2023
AI could revolutionize sudden cardiac death prediction and prevention

AI could revolutionize sudden cardiac death prediction and prevention

Reviewed byMegan Craig, M.Sc.Nov 6 2023Predicting sudden cardiac death, and perhaps even addressing a person's risk to prevent future death, may be possible through artificial intelligence (
World medicine November 25,2023
Lazertinib Outperforms Gefitinib in EGFR-Mutated NSCLC

Lazertinib Outperforms Gefitinib in EGFR-Mutated NSCLC

July 18, 2023Kyle DohertyThe third-generation EGFR TKI lazertinibdisplayed a significant efficacy improvement compared with gefitinibin patients with EGFR-mutated advanced non–small cell l
World medicine November 25,2023
Lazertinib Outperforms Gefitinib in EGFR-Mutated NSCLC

Lazertinib Outperforms Gefitinib in EGFR-Mutated NSCLC

July 18, 2023Kyle DohertyThe third-generation EGFR TKI lazertinibdisplayed a significant efficacy improvement compared with gefitinibin patients with EGFR-mutated advanced non–small cell l
World medicine November 25,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com